Benjamin H. Pensak counsels clients on technology transactions and related corporate matters, primarily in the life sciences industry. Ben represents international and US-based public and private companies and institutions, and his clients include biotechnology, pharmaceutical, medical device, diagnostics, digital health, and medical informatics companies. Ben advises clients on negotiating and structuring acquisitions, divestitures, joint ventures, corporate partnering, licensing, and other complex collaborations. He also drafts and negotiates day-to-day technical contractual arrangements. He is the deputy leader of the firm's life sciences transactions practice.
In his transactional work, Ben handles arrangements related to discovery, development, manufacture and supply, marketing, and outsourcing for life sciences companies and other innovative and developed technology companies. He also works with research organizations and institutions.
While earning his undergraduate degree in religion, Ben conducted a range of microbiology research focused primarily on gene therapy.
Leading Lawyer, Intellectual property: Patents: licensing, The Legal 500 US (2022–2024)
Next Generation Partner, Industry focus: Healthcare: life sciences, The Legal 500 US (2019–2024)
Recommended, Intellectual property: Patents: licensing, The Legal 500 US (2019–2021)
Life Sciences Star, Licensing & Collaboration, Mergers & Acquisitions, LMG Life Sciences Awards Americas (2023, 2024)
Life Sciences Star, Financial and Corporate, LMG Life Sciences (2018–2022)
Up and Coming, Life Sciences: Corporate/Commercial, California, Chambers USA (2018, 2019)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)